Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063714
Filing Date
2023-11-14
Accepted
2023-11-14 16:15:26
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-20230930.htm   iXBRL 10-Q 1998055
2 EX-31.1 hrtx-ex31_1.htm EX-31.1 18006
3 EX-31.2 hrtx-ex31_2.htm EX-31.2 17670
4 EX-32.1 hrtx-ex32_1.htm EX-32.1 20425
  Complete submission text file 0000950170-23-063714.txt   7971076

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrtx-20230930_def.xml EX-101.DEF 151611
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hrtx-20230930_cal.xml EX-101.CAL 43213
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrtx-20230930_pre.xml EX-101.PRE 271728
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrtx-20230930_lab.xml EX-101.LAB 386242
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrtx-20230930.xsd EX-101.SCH 41873
56 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20230930_htm.xml XML 1636620
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 231406433
SIC: 2834 Pharmaceutical Preparations